Publications by authors named "Shugo Tamada"

Claim this Profile
M
Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.
Yoshihisa Umekita, Yasuyo Ohi, Orie Iwaya, Masakazu Souda, Yasuaki Sagara, Shugo Tamada

Histopathology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
Yasuaki Sagara, Yasuyo Ohi, Ayami Matsukata, Daisuke Yotsumoto, Shinichi Baba, Shugo Tamada

Breast Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucocele-like lesions of the breast: a long-term follow-up study.
Yasuyo Ohi, Yoshihisa Umekita, Yoshiaki Rai, Yasuaki Sagara, Shinichi Baba, Shugo Tamada

Diagn Pathol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer.
Yoshihisa Umekita, Yasuyo Ohi, Masakazu Souda, Yoshiaki Rai, Yoshiaki Sagara, Shugo Tamada

Diagn Pathol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
Shugo Tamada, Yasuaki Sagara, Shinichi Baba, Yoshiaki Sagara, Daisuke Yotsumoto

Gan To Kagaku Ryoho· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.
Yasuaki Sagara, Shoichiro Kosha, Shinichi Baba, Fumiko Dokiya, Shugo Tamada

Breast Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comparison of the pharmacokinetics and safety of a paclitaxel injection NK and Taxol injection in breast cancer patients].
Yoshiaki Sagara, Yoshiaki Rai, Yoshiatsu Sagara, Yoshito Matsuyama, Shinichi Baba, Shugo Tamada

Gan To Kagaku Ryoho· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of inflammatory breast cancer achieving pathological complete response by primary systemic therapy with CEF (cyclophosphamide, epirubicin, 5-fluorouracil) followed by docetaxel].
Yasuaki Sagara, Yoshiaki Rai, Yoshiaki Sagara, Shugo Tamada, Shinsaku Tsuchimochi

Gan To Kagaku Ryoho· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
Shugo Tamada, Hiroaki Shibahara, Michiyo Higashi, Masamichi Goto, Surinder K Batra

Clin Cancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant expression of pyloric gland-type mucin in mucin-producing bile duct carcinomas: a clear difference between the core peptide and the carbohydrate moiety.
Masamichi Goto, Hiroaki Shibahara, Shugo Tamada, Tomofumi Hamada, Koji Oda

Pathol Int· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms.
Hiroaki Shibahara, Shugo Tamada, Masamichi Goto, Koji Oda, Masato Nagino

Am J Surg Pathol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Hiroaki Shibahara, Shugo Tamada, Michiyo Higashi, Masamichi Goto, Surinder K Batra

Hepatology· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
Shugo Tamada, Masamichi Goto, Mitsuharu Nomoto, Koji Nagata, Takeshi Shimizu

Pathol Int· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis